736 related articles for article (PubMed ID: 26853747)
1. Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.
Davidson SM; Papagiannakopoulos T; Olenchock BA; Heyman JE; Keibler MA; Luengo A; Bauer MR; Jha AK; O'Brien JP; Pierce KA; Gui DY; Sullivan LB; Wasylenko TM; Subbaraj L; Chin CR; Stephanopolous G; Mott BT; Jacks T; Clish CB; Vander Heiden MG
Cell Metab; 2016 Mar; 23(3):517-28. PubMed ID: 26853747
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
Vincent EE; Sergushichev A; Griss T; Gingras MC; Samborska B; Ntimbane T; Coelho PP; Blagih J; Raissi TC; Choinière L; Bridon G; Loginicheva E; Flynn BR; Thomas EC; Tavaré JM; Avizonis D; Pause A; Elder DJ; Artyomov MN; Jones RG
Mol Cell; 2015 Oct; 60(2):195-207. PubMed ID: 26474064
[TBL] [Abstract][Full Text] [Related]
3. Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.
Mayers JR; Torrence ME; Danai LV; Papagiannakopoulos T; Davidson SM; Bauer MR; Lau AN; Ji BW; Dixit PD; Hosios AM; Muir A; Chin CR; Freinkman E; Jacks T; Wolpin BM; Vitkup D; Vander Heiden MG
Science; 2016 Sep; 353(6304):1161-5. PubMed ID: 27609895
[TBL] [Abstract][Full Text] [Related]
4. Lactate Metabolism in Human Lung Tumors.
Faubert B; Li KY; Cai L; Hensley CT; Kim J; Zacharias LG; Yang C; Do QN; Doucette S; Burguete D; Li H; Huet G; Yuan Q; Wigal T; Butt Y; Ni M; Torrealba J; Oliver D; Lenkinski RE; Malloy CR; Wachsmann JW; Young JD; Kernstine K; DeBerardinis RJ
Cell; 2017 Oct; 171(2):358-371.e9. PubMed ID: 28985563
[TBL] [Abstract][Full Text] [Related]
5. Targeting metabolic reprogramming in KRAS-driven cancers.
Kawada K; Toda K; Sakai Y
Int J Clin Oncol; 2017 Aug; 22(4):651-659. PubMed ID: 28647837
[TBL] [Abstract][Full Text] [Related]
6. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
7. Loss of Fer Jeopardizes Metabolic Plasticity and Mitochondrial Homeostasis in Lung and Breast Carcinoma Cells.
Mehazri L; Shpungin S; Bel S; Nir U
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806191
[TBL] [Abstract][Full Text] [Related]
8. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
[TBL] [Abstract][Full Text] [Related]
9. Autophagy is required for glucose homeostasis and lung tumor maintenance.
Karsli-Uzunbas G; Guo JY; Price S; Teng X; Laddha SV; Khor S; Kalaany NY; Jacks T; Chan CS; Rabinowitz JD; White E
Cancer Discov; 2014 Aug; 4(8):914-27. PubMed ID: 24875857
[TBL] [Abstract][Full Text] [Related]
10. Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.
Brunelli L; Caiola E; Marabese M; Broggini M; Pastorelli R
Sci Rep; 2016 Jun; 6():28398. PubMed ID: 27329432
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Heterogeneity in Human Lung Tumors.
Hensley CT; Faubert B; Yuan Q; Lev-Cohain N; Jin E; Kim J; Jiang L; Ko B; Skelton R; Loudat L; Wodzak M; Klimko C; McMillan E; Butt Y; Ni M; Oliver D; Torrealba J; Malloy CR; Kernstine K; Lenkinski RE; DeBerardinis RJ
Cell; 2016 Feb; 164(4):681-94. PubMed ID: 26853473
[TBL] [Abstract][Full Text] [Related]
12. Nitrilase 1 modulates lung tumor progression in vitro and in vivo.
Wang YA; Sun Y; Le Blanc JM; Solomides C; Zhan T; Lu B
Oncotarget; 2016 Apr; 7(16):21381-92. PubMed ID: 26967383
[TBL] [Abstract][Full Text] [Related]
13. Macrophages are metabolically heterogeneous within the tumor microenvironment.
Geeraerts X; Fernández-Garcia J; Hartmann FJ; de Goede KE; Martens L; Elkrim Y; Debraekeleer A; Stijlemans B; Vandekeere A; Rinaldi G; De Rycke R; Planque M; Broekaert D; Meinster E; Clappaert E; Bardet P; Murgaski A; Gysemans C; Nana FA; Saeys Y; Bendall SC; Laoui D; Van den Bossche J; Fendt SM; Van Ginderachter JA
Cell Rep; 2021 Dec; 37(13):110171. PubMed ID: 34965415
[TBL] [Abstract][Full Text] [Related]
14. Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.
Ohm AM; Tan AC; Heasley LE; Reyland ME
Oncogene; 2017 Jul; 36(30):4370-4378. PubMed ID: 28368426
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer.
Liao ZX; Kempson IM; Hsieh CC; Tseng SJ; Yang PC
Drug Discov Today; 2021 Nov; 26(11):2508-2514. PubMed ID: 34325010
[TBL] [Abstract][Full Text] [Related]
16. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
[TBL] [Abstract][Full Text] [Related]
17. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Yu T; Chen X; Zhang W; Liu J; Avdiushko R; Napier DL; Liu AX; Neltner JM; Wang C; Cohen D; Liu C
Cell Death Differ; 2016 Feb; 23(2):207-15. PubMed ID: 26113043
[TBL] [Abstract][Full Text] [Related]
18. Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS.
Caiola E; Brunelli L; Marabese M; Broggini M; Lupi M; Pastorelli R
Oncotarget; 2016 Aug; 7(32):51462-51472. PubMed ID: 27283493
[TBL] [Abstract][Full Text] [Related]
19. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
20. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
